Shanghai Shyndec Pharmaceutical Co Ltd (600420) — Tangible Net Worth Ratio
Shanghai Shyndec Pharmaceutical Co Ltd (600420) has a Tangible Net Worth Ratio of 93.8% as of June 2026. This metric is calculated by deducting intangible assets (CN¥982.24 Million) from net assets (CN¥15.93 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore 600420 net assets growth trend to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Shanghai Shyndec Pharmaceutical Co Ltd Tangible Net Worth Ratio (2001–2025)
This chart shows how Shanghai Shyndec Pharmaceutical Co Ltd's Tangible Net Worth Ratio has changed across 25 annual periods from 2001 to 2025. As of June 2026, the ratio stands at 93.8%, reflecting net assets of CN¥15.93 Billion with intangible assets of CN¥982.24 Million CNY. For live market cap and overall valuation, see Shanghai Shyndec Pharmaceutical Co Ltd (600420) total market value.
Annual Tangible Net Worth Ratio for Shanghai Shyndec Pharmaceutical Co Ltd (2001–2025)
The table below presents the year-by-year Tangible Net Worth Ratio for Shanghai Shyndec Pharmaceutical Co Ltd from 2001 to 2025, covering 25 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. Explore Shanghai Shyndec Pharmaceutical Co Ltd (600420) capital reinvestment to see what proportion of operating cash flow is directed to capital expenditures.
| Year | Tangible NW Ratio | Net Assets (CNY) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 97.3% | CN¥34.93 Billion | CN¥959.52 Million | CN¥19.23 Billion | ▲ +3.1 pp |
| 2024 | 94.1% | CN¥15.32 Billion | CN¥897.05 Million | CN¥19.96 Billion | ▼ -0.2 pp |
| 2023 | 94.3% | CN¥14.34 Billion | CN¥814.12 Million | CN¥19.35 Billion | ▲ +0.4 pp |
| 2022 | 94.0% | CN¥12.15 Billion | CN¥733.20 Million | CN¥19.63 Billion | ▲ +0.5 pp |
| 2021 | 93.5% | CN¥10.37 Billion | CN¥675.85 Million | CN¥19.07 Billion | ▲ +0.1 pp |
| 2020 | 93.4% | CN¥9.82 Billion | CN¥647.14 Million | CN¥18.25 Billion | ▲ +0.7 pp |
| 2019 | 92.7% | CN¥9.20 Billion | CN¥672.99 Million | CN¥17.64 Billion | ▲ +1.2 pp |
| 2018 | 91.5% | CN¥8.44 Billion | CN¥718.00 Million | CN¥16.46 Billion | ▲ +1.6 pp |
| 2017 | 89.9% | CN¥7.65 Billion | CN¥773.81 Million | CN¥15.17 Billion | ▲ +1.6 pp |
| 2016 | 88.3% | CN¥6.94 Billion | CN¥812.45 Million | CN¥15.02 Billion | ▲ +3.7 pp |
| 2015 | 84.6% | CN¥1.61 Billion | CN¥248.23 Million | CN¥4.14 Billion | ▲ +0.2 pp |
| 2014 | 84.4% | CN¥1.39 Billion | CN¥216.97 Million | CN¥3.81 Billion | ▼ -0.6 pp |
| 2013 | 85.0% | CN¥1.33 Billion | CN¥199.14 Million | CN¥3.15 Billion | ▲ +0.2 pp |
| 2012 | 84.8% | CN¥1.19 Billion | CN¥181.46 Million | CN¥2.47 Billion | ▲ +0.1 pp |
| 2011 | 84.6% | CN¥947.63 Million | CN¥145.83 Million | CN¥1.49 Billion | ▼ -0.3 pp |
| 2010 | 85.0% | CN¥837.59 Million | CN¥126.03 Million | CN¥1.14 Billion | ▼ -4.8 pp |
| 2009 | 89.8% | CN¥713.46 Million | CN¥72.89 Million | CN¥927.71 Million | ▼ -0.7 pp |
| 2008 | 90.5% | CN¥631.47 Million | CN¥59.82 Million | CN¥794.87 Million | ▼ -0.6 pp |
| 2007 | 91.1% | CN¥594.29 Million | CN¥52.81 Million | CN¥713.86 Million | ▼ -3.2 pp |
| 2006 | 94.3% | CN¥511.49 Million | CN¥29.02 Million | CN¥597.64 Million | ▲ +0.9 pp |
| 2005 | 93.4% | CN¥478.84 Million | CN¥31.44 Million | CN¥585.51 Million | ▼ -0.1 pp |
| 2004 | 93.6% | CN¥441.88 Million | CN¥28.43 Million | CN¥516.19 Million | ▲ +12.4 pp |
| 2003 | 81.2% | CN¥143.00 Million | CN¥26.92 Million | CN¥262.10 Million | ▲ +1.9 pp |
| 2002 | 79.3% | CN¥114.68 Million | CN¥23.77 Million | CN¥203.58 Million | ▼ -7.9 pp |
| 2001 | 87.2% | CN¥95.12 Million | CN¥12.16 Million | CN¥175.79 Million | — |